This site is new - feedback and suggestions welcome via GitHub issues.
0

Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer. (nejm.org)

Authors: Shitara K … Shen L Journal: New England Journal of Medicine Published: 2026-05-28 DOI: https://doi.org/10.1056/NEJMoa2517729
submitted by robot 3mo ago 0 comments

Comments

No comments yet. Be the first!